Found 8 matching trials
Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer PHASE3 This is a randomized, prospective, multicenter, open-label, Phase III clini...
Show More Status
Active Not Recruiting
Location
Sir Run Run Shao hospital
Learn More & Join Trial
Modified Short-Course Radiotherapy Combined With Immunochemotherapy and Targeted Therapy as First-Line Treatment for MSS Metastatic Colorectal Cancer PHASE2 This is a single-arm interventional study targeting patients with initially...
Show More Status
Active Not Recruiting
Location
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II) PHASE2 Most rectal cancers are microsatellite stable (MSS) or mismatch repair-prof...
Show More Location
The Sixth Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Node-Sparing Short-Course Radiation With CAPOX and Sintilimab for MSS Locally Advanced Colon Cancer: A Randomized, Prospective, Multicenter Study PHASE2 This study aims to evaluate the use of node-sparing short-course radiothera...
Show More Location
Sir Run Run Shaw Hospital, Zhejiang University
Learn More & Join Trial
Node-Sparing Hypofractionated Radiotherapy Plus Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Randomized, Phase II Trial PHASE2 Most colorectal cancers are microsatellite stable (MSS) or mismatch repair-...
Show More Location
The Sixth Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer PHASE2 This is an open-label, prospective, multicenter phase II clinical trial to ...
Show More Location
Sir Run Run Shao hospital
Learn More & Join Trial
Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MSS Colorectal Cancer (MODIFI-CRC) PHASE2 The current standard first-line treatment for metastatic colorectal cancer ...
Show More Location
The Sixth Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Node-Sparing Short-Course Radiotherapy Plus First-Line Therapy and PD-1 Inhibitor in Unresectable/Metastastic pMMR/MSS Gastric Cancer (MODIFI-GC) PHASE2 For patients with unresectable locally advanced or metastatic gastric cance...
Show More Location
The Sixth Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial